Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
Pharmaceutics · 11.09.2024 · 16 (9) · 1197
DOI: 10.3390/pharmaceutics16091197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.09.2024. Verfasst von Minse Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic …. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea grant funded by the Korean government by Korea In-stitute of Planning, Ministry of Science and ICT, Global - Learning & Academic research institution for Master's PhD students, and Postdocs (LAMP) Program of the National Research Foundation of Korea(NRF) gran….
Abstract (Originalsprache)
The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system is a gene-editing technology. Nanoparticle delivery systems have attracted attention because of the limitations of conventional viral vectors. In this review, we assess the efficiency of various nanoparticles, including lipid-based, polymer-based, inorganic, and extracellular vesicle-based systems, as non-viral vectors for CRISPR/Cas9 delivery. We discuss their advantages, limitations, and current challenges. By summarizing recent advancements and highlighting key strategies, this review aims to provide a comprehensive overview of the role of non-viral delivery systems in advancing CRISPR/Cas9 technology for clinical applications and gene therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Department of Smart Health Science and Technology, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Multidimensional Genomics Research Center, Kangwon National University, Chuncheon 24341, Republic of Korea.
ORCID-Profile: Youngwoo Hwang, Hyeon-Ki Jang, Hyun-Ouk Kim
Förderung
- National Research Foundation of Korea grant funded by the Korean government by Korea In-stitute of Planning
- Ministry of Science and ICT
- Global - Learning & Academic research institution for Master's PhD students, and Postdocs (LAMP) Program of the National Research Foundation of Korea(NRF) gran…
- National Research Foundation of Korea
- Global-Learning & Academic research institution
- Postdocs (LAMP) Program of the National Research Foundation of Korea (NRF)
Zitieren
APA
Kim, M., Hwang, Y., Lim, S., Jang, H. K., & Kim, H. O. (2024). Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9. Pharmaceutics, 16(9), 1197. https://doi.org/10.3390/pharmaceutics16091197
Vancouver
Kim M, Hwang Y, Lim S, Jang HK, Kim HO. Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9. Pharmaceutics. 2024;16(9):1197. doi:10.3390/pharmaceutics16091197
BibTeX
@article{Kim2024,
author = {Kim, Minse and Hwang, Youngwoo and Lim, Seongyu and Jang, Hyeon-Ki and Kim, Hyun-Ouk},
title = {Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {9},
pages = {1197},
doi = {10.3390/pharmaceutics16091197}
}
EUVIMED